3/22
07:36 am
sls
Assessing SELLAS Life Sciences Group (SLS) Valuation After Its Sharp Recent Share Price Run [Yahoo! Finance]
High
Report
Assessing SELLAS Life Sciences Group (SLS) Valuation After Its Sharp Recent Share Price Run [Yahoo! Finance]
3/20
08:22 am
sls
SELLAS Stock Up 346% in a Year as Cancer Vaccine Trial Nears Its Final 8 Deaths [Yahoo! Finance]
Medium
Report
SELLAS Stock Up 346% in a Year as Cancer Vaccine Trial Nears Its Final 8 Deaths [Yahoo! Finance]
3/19
04:55 pm
sls
SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
3/19
04:45 pm
sls
SELLAS Life Sciences GAAP EPS of -$0.25 beats by $0.01 [Seeking Alpha]
Medium
Report
SELLAS Life Sciences GAAP EPS of -$0.25 beats by $0.01 [Seeking Alpha]
3/19
04:05 pm
sls
SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update
Medium
Report
SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update
3/17
05:14 pm
sls
SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference [Yahoo! Finance]
Medium
Report
SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference [Yahoo! Finance]
3/17
04:30 pm
sls
SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference
Low
Report
SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference
3/16
08:04 am
sls
SELLAS Life Sciences Group (SLS) had its price target raised by Maxim Group from $7.00 to $10.00. They now have a "buy" rating on the stock.
Low
Report
SELLAS Life Sciences Group (SLS) had its price target raised by Maxim Group from $7.00 to $10.00. They now have a "buy" rating on the stock.
3/12
08:42 am
sls
SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009 [Yahoo! Finance]
Medium
Report
SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009 [Yahoo! Finance]
3/12
08:35 am
sls
SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009
Medium
Report
SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009
3/9
10:36 pm
sls
SELLAS Life Sciences (SLS) Is Up 18.0% After Positive AML Trial Updates – What's Changed [Yahoo! Finance]
Medium
Report
SELLAS Life Sciences (SLS) Is Up 18.0% After Positive AML Trial Updates – What's Changed [Yahoo! Finance]
3/7
12:36 pm
sls
Assessing SELLAS Life Sciences Group (SLS) Valuation After Recent Leukemia Trial Updates [Yahoo! Finance]
Medium
Report
Assessing SELLAS Life Sciences Group (SLS) Valuation After Recent Leukemia Trial Updates [Yahoo! Finance]
3/5
12:07 pm
sls
Sellas Life Sciences: REGAL Study Results Due Any Day Are A Major Potential Upside Catalyst [Seeking Alpha]
Low
Report
Sellas Life Sciences: REGAL Study Results Due Any Day Are A Major Potential Upside Catalyst [Seeking Alpha]
1/19
08:11 am
sls
Why I'm Selling Sellas Life Sciences Ahead Of The REGAL Reveal [Seeking Alpha]
Medium
Report
Why I'm Selling Sellas Life Sciences Ahead Of The REGAL Reveal [Seeking Alpha]
1/14
07:36 pm
sls
A Look At SELLAS Life Sciences Group (SLS) Valuation After New IMPACT AML Clinical Study Agreement [Yahoo! Finance]
Medium
Report
A Look At SELLAS Life Sciences Group (SLS) Valuation After New IMPACT AML Clinical Study Agreement [Yahoo! Finance]
1/14
08:30 am
sls
SELLAS Life Sciences Enters Agreement with IMPACT-AML to Expand SLS009 Clinical Program into Europe
Low
Report
SELLAS Life Sciences Enters Agreement with IMPACT-AML to Expand SLS009 Clinical Program into Europe
1/6
08:27 am
sls
SELLAS Life Sciences Group (SLS) Is Up 50.8% After REGAL Trial Nears Final OS Trigger - Has The Bull Case Changed? [Yahoo! Finance]
High
Report
SELLAS Life Sciences Group (SLS) Is Up 50.8% After REGAL Trial Nears Final OS Trigger - Has The Bull Case Changed? [Yahoo! Finance]
12/29
09:02 am
sls
SELLAS Life Sciences Provides Update on Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) [Yahoo! Finance]
High
Report
SELLAS Life Sciences Provides Update on Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) [Yahoo! Finance]
12/29
08:35 am
sls
SELLAS Life Sciences Provides Update on Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML)
High
Report
SELLAS Life Sciences Provides Update on Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML)
12/25
11:47 am
sls
Assessing SELLAS Life Sciences Group (SLS) Valuation After Positive Leukemia Data and Supportive FDA Designations [Yahoo! Finance]
Low
Report
Assessing SELLAS Life Sciences Group (SLS) Valuation After Positive Leukemia Data and Supportive FDA Designations [Yahoo! Finance]